| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.21 | $66.40 (0%) | 🛒 Add to cart |
| 60 | $1.79 | $132.80 $107.64 (19%) | 🛒 Add to cart |
| 90 | $1.64 | $199.19 $147.89 (26%) | 🛒 Add to cart |
| 120 | $1.58 | $265.59 $189.13 (29%) | 🛒 Add to cart |
| 180 | $1.50 | $398.39 $270.62 (32%) | 🛒 Add to cart |
| 270 | $1.45
Best per pill | $597.58 $392.35 (34%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
rosuvastatin
Rosuvastatin represents one of the most significant advances in cardiovascular pharmacotherapy over the past two decades. As a third-generation statin, this HMG-CoA reductase inhibitor demonstrates exceptional potency in lipid management, with particular efficacy in reducing atherogenic lipoproteins. What began as another cholesterol-lowering agent has evolved into a cornerstone therapy for atherosclerotic cardiovascular disease prevention across multiple patient populations. Key Components and Bioavailability Rosuvastatin The molecular structure of rosuvastatin features a unique polar methane-sulfonamide group that distinguishes it from earlier statins.
atorlip 10
Before we dive into the formal monograph, let me give you the real story on Atorlip 10. When our team first started working on this formulation, we had this massive debate about the excipient matrix – the head of pharmaceutics kept insisting we needed a full wet granulation process for stability, while the clinical lead argued it would delay release kinetics by nearly 40 minutes. We actually had to run three separate pilot batches to settle it, and honestly, the data surprised everyone – the direct compression method we eventually used not only maintained stability but actually improved the initial dissolution profile in gastric pH.
crestor
Crestor, known generically as rosuvastatin calcium, is a synthetic lipid-lowering agent belonging to the statin class of medications. Marketed globally by AstraZeneca, this HMG-CoA reductase inhibitor represents one of the most potent prescription medications available for managing dyslipidemia. Unlike many dietary supplements that make vague health claims, Crestor operates through a well-defined biochemical pathway with extensive clinical validation spanning decades of research and real-world application. Crestor: Potent LDL-C Reduction for Cardiovascular Risk Management - Evidence-Based Review 1.
lipitor
Lipitor, known generically as atorvastatin calcium, represents one of the most widely prescribed and extensively studied HMG-CoA reductase inhibitors in modern cardiovascular pharmacotherapy. As a cornerstone of lipid management, its primary role involves significant reduction of low-density lipoprotein cholesterol (LDL-C) and stabilization of atherosclerotic plaques, fundamentally altering the trajectory of atherosclerotic cardiovascular disease (ASCVD) risk. The development journey wasn’t straightforward—our initial clinical trials team debated fiercely about the optimal dosing strategy, with some advocating for more aggressive titration while others worried about muscle-related adverse events.
Lopid: Comprehensive Lipid Management for Cardiovascular Risk Reduction - Evidence-Based Review
Gemfibrozil, marketed under the brand name Lopid, represents a significant advancement in the management of dyslipidemia, particularly for patients with specific lipid profile abnormalities that don’t respond adequately to lifestyle modifications alone. This fibric acid derivative has carved out its niche in cardiovascular risk reduction by targeting triglycerides with notable efficacy while simultaneously addressing other lipid parameters. What’s fascinating about Lopid isn’t just its mechanism—which we’ll explore in depth—but how it fits into the broader landscape of lipid management, especially for those patients who fall into that tricky middle ground where statins alone don’t provide complete solutions.
pravachol
Pravastatin sodium, the active pharmaceutical ingredient in Pravachol, represents a cornerstone in modern lipid management therapy. As an HMG-CoA reductase inhibitor, it specifically targets hepatic cholesterol synthesis, producing significant reductions in LDL-C while offering a favorable safety profile that’s made it a first-line option for decades. What’s fascinating isn’t just its mechanism—which we’ll explore in depth—but how its hydrophilic properties create a distinct clinical advantage over lipophilic statins when considering muscle-related adverse events.
zetia
Ezetimibe, marketed as Zetia, represents one of the more interesting pharmacological developments in lipid management over the past two decades. Unlike statins that work primarily in the liver to inhibit cholesterol synthesis, ezetimibe operates through a completely different mechanism—blocking dietary cholesterol absorption at the brush border of the small intestine. This dual-pathway approach to cholesterol reduction has created both opportunities and controversies in cardiovascular prevention. The drug exists as a single-agent tablet containing 10mg of ezetimibe, though it’s frequently combined with statins in fixed-dose combinations like Vytorin (ezetimibe/simvastatin).
zocor
Simvastatin, marketed under the brand name Zocor, represents a cornerstone in the pharmacological management of dyslipidemia. This lipid-lowering medication belongs to the statin class (HMG-CoA reductase inhibitors) and has been extensively studied in landmark clinical trials. Its introduction fundamentally changed cardiovascular risk reduction strategies. When I first started prescribing it in the late 90s, we were still grappling with the limitations of older agents like fibrates and resins. The arrival of Zocor gave us our first truly powerful tool for LDL-C reduction with a manageable side effect profile.
a ret gel
A topical retinoid gel containing 0.025% tretinoin in a stabilized hydrogel base, designed for gradual release and reduced irritation compared to traditional formulations. The formulation includes niacinamide 4% to enhance barrier function and hyaluronic acid 0.5% for sustained hydration throughout the treatment period. Key Components and Bioavailability of Ret Gel The ret gel formulation represents a significant advancement in topical retinoid delivery systems. The primary active ingredient, tretinoin at 0.025% concentration, is stabilized through microencapsulation technology that protects the molecule from oxidative degradation while allowing controlled release.